Macau, China vs Trinidad and Tobago: Tuberculosis cases
Macau, China
420 cases
in 2024
Trinidad and Tobago
400 cases
in 2024
Macau, China rank
139th
Trinidad and Tobago rank
142nd
Tuberculosis cases over time
- Macau, China
- Trinidad and Tobago
How they compare
Macau, China currently reports 420 cases against 400 cases in Trinidad and Tobago, a difference of 20 cases.
That makes Macau, China's figure about 1.1 times Trinidad and Tobago's.
Across all 25 years both countries report, Macau, China has been ahead every year.
Macau, China ranks 139th and Trinidad and Tobago ranks 142nd of 215 countries.
Macau, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Macau, China | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 850 cases | 353 cases | 497 cases | Macau, China |
| 2010s | 625 cases | 311 cases | 314 cases | Macau, China |
| 2020s | 486 cases | 324 cases | 162 cases | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis cases, Macau, China or Trinidad and Tobago?
- Macau, China, at 420 cases against 400 cases in Trinidad and Tobago as of 2024.
- What is the difference in tuberculosis cases between Macau, China and Trinidad and Tobago?
- 20 cases, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Trinidad and Tobago?
- 25 years are reported by both, from 2000 to 2024.
- How do Macau, China and Trinidad and Tobago rank globally for tuberculosis cases?
- Macau, China ranks 139th and Trinidad and Tobago ranks 142nd of 215 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated number of new and relapse tuberculosis cases arising in a given year. All forms of the disease are included, including cases in people living with HIV.